Coromandel International Ltd

Coromandel International announced that the Board of Directors of the Company at its meeting held on 29 January 2026, inter alia, have recommended the interim dividend of Rs 9 per equity Share (i.e. 900%) , subject to the approval of the shareholders.Powered by Capital Market - Live

However, revenue from operations rose 26.58% to Rs 8,779.15 crore in Q3 FY26, compared with Rs 6,935.19 crore in Q3 FY25. Profit before tax stood at Rs 652.76 crore in Q3 FY26, down 4.44% compared with Rs 683.12 crore in Q3 FY25. Total expenses rose 29.14% to Rs 8,209.88 crore in Q3 FY26, compared with Rs 6,357.26 crore in Q3 FY25. Cost of material consumed stood at Rs 4,795.14 core (up 42.70%YoY), finance cost was at Rs 285.88 (up 39.73% YoY) during the period under the review. In Q3 FY26, revenue from the nutrient and other allied business rose 21.89% year on year to Rs 7,761.77 crore and revenue from crop protection segment jumped 72.77% year on year to Rs 1,098.27 crore in Q3 FY26. The company has declared an interim dividend of Rs 9 per equity share (900%) for FY26 on shares with a face value of Re 1 each. The dividend will be paid on or after February 18, 2026, and within 30 days of declaration. The record date for determining eligible shareholders has been fixed as February 4, 2026. Coromandel International is one of India's leading agri solutions provider. It offers a diverse range of products and services across the farming value chain. It specializes in fertilizers, crop protein, bio pesticide, specialty nutrients, organic fertilizers, etc. Shares of Coromandel International rose 0.38% to end at Rs 2,265.40 on the BSE. Powered by Capital Market - Live

Net profit of Coromandel International declined 1.15% to Rs 505.88 crore in the quarter ended December 2025 as against Rs 511.77 crore during the previous quarter ended December 2024. Sales rose 26.59% to Rs 8779.45 crore in the quarter ended December 2025 as against Rs 6935.19 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales8779.456935.19 27 OPM %9.1110.29 - PBDT799.31753.87 6 PBT652.76683.12 -4 NP505.88511.77 -1 Powered by Capital Market - Live

Coromandel International will hold a meeting of the Board of Directors of the Company on 29 January 2026.Powered by Capital Market - Live

Coromandel International has executed a non-binding Memorandum of Understanding (MoU) with the Andhra Pradesh Economic Development Board (APEDB), Government of Andhra Pradesh, on 13 November 2025. This MoU outlines a proposed investment of up to Rs 2,000 crore subject to necessary approvals, towards various initiatives aligned with the Company's business objectives and aimed at contributing to the industrial development of Andhra Pradesh. The MoU serves as a framework to facilitate the execution of these projects in a time-bound manner, in accordance with the prevailing policies, rules, and regulations of the Government of Andhra Pradesh. Powered by Capital Market - Live

Net profit of Coromandel International rose 21.28% to Rs 805.33 crore in the quarter ended September 2025 as against Rs 664.05 crore during the previous quarter ended September 2024. Sales rose 29.88% to Rs 9654.13 crore in the quarter ended September 2025 as against Rs 7432.83 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales9654.137432.83 30 OPM %11.8812.94 - PBDT1161.21960.83 21 PBT1059.45891.85 19 NP805.33664.05 21 Powered by Capital Market - Live

Coromandel International will hold a meeting of the Board of Directors of the Company on 30 October 2025.Powered by Capital Market - Live

The board of Coromandel International at its meeting held on 22 September 2025 has approved setting up of a technical mono ammonium phosphate (TMAP) plant at Visakhapatnam. Powered by Capital Market - Live

Coromandel International has acquired 5,435 equity shares of NACL Industries (NACL) at the offer price of Rs. 76.70/- per equity share from the public shareholders of NACL which were tendered during the tendering period of the open offer made by the Company in accordance with applicable regulations of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Pursuant to this acquisition, the Company owns in aggregate 10,69,12,581 equity shares (representing 53.08% of the voting share capital) of NACL. Powered by Capital Market - Live

The agency has also affirmed the company's short-term rating at 'IND A1+'. India Ratings & Research stated that the affirmation reflects CIL's strong business profile as India's second-largest phosphatic fertilizer player and largest single super phosphate (SSP) player. Its EBITDA margins remain resilient due to backward integration for sourcing of fertilizer raw material, improving proportion of non-subsidy revenue and healthy contribution from unique formulations. CIL's strong credit metrics are driven by a healthy EBITDA generation and capex funded through internal accruals. The liquidity position of the company is adequate, backed by healthy cash balances, liquid investments, and inter-corporate deposits. However, factors like deterioration in the operating profitability or any adverse regulatory policy movement and/or the consolidated net leverage exceeding 1.0x on a sustained basis could lead to a negative rating action. Coromandel International, a flagship company of the Murugappa Group, operates in two segments: crop protection chemicals (CPC) and nutrients and allied business (NAB). The NAB segment comprises of phosphatic fertilisers (di-ammonium phosphate, complexes, single super phosphate, muriate of potash); specialty nutrients and organic fertilisers (G-sulphur, water soluble fertilisers, organic manure); and the retail stores business that provides agri inputs and agri services. The CPC segment comprises technical materials, formulations and biopesticides. Its facilities are spread across India but are largely concentrated in south India. The company's consolidated net profit jumped 62.40% to Rs 505.01 crore on a 48.92% increase in revenue to Rs 7,042.30 crore in Q1 FY26 as compared with Q1 FY25. The scrip shed 0.60% to currently trade at Rs 2407 on the BSE. Powered by Capital Market - Live